Abstract
In recent years, the prophylactic treatment of primary headaches has been widely developed both in the theoretical and practical fields. New lines of drugs, non-pharmacological strategies and combined, sometimes highly effective approaches are responsible for this development. Nevertheless, despite the great number of controlled clinical trials on headache prophylaxis, similar approaches have not been provided in the management of the acute phase of headache. Thus, the chances of a successful outcome in this field are as limited as in the past. Treatment is restricted to the use of either ergotamine derivatives or various combination products, or nonsteroidal anti-inflammatory drugs which are widely used in many other painful conditions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ad Hoc Committee on Classification of Headache of the NIH (1962). JAMA 179: 717–718
Dichgans J, Diener HC, Gerber WD, Verspohl EJ, Kukiolka H, Kluck M (1984) Analgetika-induzierter Dauerkopfschmerz. Dtsch Med Wochenschr 109: 369–373
Dunnel K, Cartwright A (1972) Medicine takers, prescribers and hoarders. Routledge and Kegan, London
Genazzani AR, Nappi G, Facchinetti F, Micieli G, Petraglia F, Bono G, Monittola C, Savoldi F (1984) Progressive impairment of CSF B-EP levels in migraine sufferers. Pain 18:127–133
Hokkanen E, Waltimo O, Kallaranta T (1978) Toxic effects of ergotamine used for migraine. Headache 18: 95–98
Hornung G, Gutscher H (1984) Medikamentenabusus: Ergebnisse einer Repräsentativerhebung in der deutschsprachigen Schweiz. Drogalkohol (Lausanne) 8: 3–24
Isler H (1982) Migraine treatment as a cause of chronic migraine. In: Rose FC (ed) Advances in migraine research and therapy. Raven, New York, pp 159–164
Kudrow L (1982) Paradoxical effects of frequent analgesic use. In: Critchley M, Friedman AP, Gorini S, Sicuteri F (eds) Advances in neurology, vol 33. Raven, New York, pp 335–341
Langemark M, Olesen J (1984) Drug abuse in migraine patients. Pain 19: 81–86
Lucas RN, Falkowsky W (1973) Ergotamine and methysergide abuse in patients with migraine. Br J Psychiatry 122: 199–203
Mathew NT, Reuveni U, Perez F (1987) Transformed or evolutive migraine. Headache 27: 102–106
Nappi G, Savoldi F (1985) Headache. Diagnostic system and taxonomic criteria. Libbey, London
Nappi G, Facchinetti F, Martignoni E, Petraglia F, Manzoni GC, Sances G, Sandrini G, Genazzani AR (1985) Endorphin patterns within the headache spectrum disorders. Cephalalgia 5 [Suppl 2]: 201–210
Nikiforow R (1980) Headache medication habits in northern Finland. Headache 20: 274–278
Peters GA, Horton BT (1951) Headache: with special reference to the excessive use of ergotamine preparations and withdrawal effects. Mayo Clin Proc 26: 153–161
Rowsell AR, Neylan C, Wilkinson M (1973) Ergotamine-induced headaches in migrainous patients. Headache 13: 65–67
Saarela S, Yrjölä M, Isokoski M (1975) Consumption of self-selected drugs. Suomen Jääk 30: 2933
Sjaastad 0 (1980) So-called “tension headache”: a term in need of revision? Curr Med Res Opin 6: 41–54
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Micieli, G., Manzoni, G.C., Granella, F., Martignoni, E., Malferrari, G., Nappi, G. (1988). Clinical and Epidemiological Observations on Drug Abuse in Headache Patients. In: Diener, HC., Wilkinson, M. (eds) Drug-Induced Headache. Advances in Applied Neurological Sciences, vol 5. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73327-7_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-73327-7_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73329-1
Online ISBN: 978-3-642-73327-7
eBook Packages: Springer Book Archive